Biomedix, a leader in advanced diagnostic technology in vascular health, is proud to announce the donation of its cutting-edge PADnet 5th generation device, PADnet Xpress, and accompanying digital health assessments to the New York College of Podiatric Medicine (NYCPM). This …
Biomedix Expands Peripheral Vascular Disease Detection to Mobile Devices Twin Cities, MN — December 4th, 2024 — Today, Biomedix announced the availability of PADnet Xpress for Android devices. PADnet Xpress is the latest edition to the PADnet diagnostic technology designed …
Twin Cities, MN — Biomedix, a pioneer in medical technology and innovation, has announced a clinical and educational sponsorship with the Western University of Health Sciences (WesternU) College of Podiatric Medicine. Established as part of Western University of Health Sciences, …
HITRUST r2 Certification validates Biomedix is committed to strong cybersecurity and protecting sensitive data. St. Paul MN, September 3rd, 2024 – Biomedix, a leading provider of front-line diagnostic solutions for healthcare organizations, today announced its Biomedix Xchange and PADnet solutions …
Biomedix has developed a unique PADnet patient-facing video for our customers! Designed to help providers educate patients about Peripheral Artery Disease and the PADnet test, this video is ideal for healthcare practices to play in waiting rooms, show to patients …
Twin Cities, MN— October 5th, 2023 — Biomedix, a market-leading medical technology and innovation company, was invited to screen congressional representatives and their staff at the United States Capitol with PADnet Xpress during the PAD Caucus briefing on September 27th, …
Twin Cities, MN— October 3rd, 2023 — Biomedix, a market-leading medical technology and innovation company, is proud to announce research support for Memorial Sloan Kettering Cancer Center (MSKCC), a world leader in patient care, research, and educational program. Dr. Yolanda …
Have Additional Questions About PVD And The HCC v28 Model? Fill Out The Form Below To Schedule A Consultation Notice: JavaScript is required for this content. A new version (v28) of the CMS HCC risk adjustment model was finalized earlier …
Background: Biomedix is a leading medical device and healthcare risk-assessment technology company with a portfolio of diagnostic devices and services that help guide patient care and eliminate gaps between the cost of care and compensation for care. We are seeking …
Innovative Leasing Program for MiniOmni Osteoporosis Screening Twin Cities, MN— August 25th, 2023 —Biomedix, a market-leading medical technology and innovation company, and BeamMed, a developer, manufacturer and marketer of best-in-class bone density assessment solutions, announced a new strategic partnership to …